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Abstract
Background: Cardiovascular disease is one of the leading causes of morbidity and mortality in Vietnam. We conducted a
pilot study of Hanoi residents hospitalized with a first acute myocardial infarction (AMI) at the Vietnam National Heart
Institute in Hanoi for purposes of describing the prevalence of cardiovascular (CVD) and non-CVD comorbidities and their
impact on hospital management, in-hospital clinical complications, and short-term mortality in these patients.
Methods: The study population consisted of 302 Hanoi residents hospitalized with a first AMI at the largest tertiary care
medical center in Hanoi in 2010.
Results: The average age of study patients was 66 years and one third were women. The proportions of patients with none,
any 1, and $ 2 CVD comorbidities were 34%, 42%, and 24%, respectively. Among the CVD comorbidities, hypertension was
the most commonly reported (59%). There were decreasing trends in the proportion of patients who were treated with
effective cardiac medications and coronary interventions as the number of CVD comorbidities increased. Patients with
multiple CVD comorbidities tended to develop acute clinical complications and die at higher rates during hospitalization
compared with patients with no CVD comorbidities (Odds Ratio: 1.40; 95% Confidence Interval: 0.40–4.84).
Conclusions: Our data suggest that patients with multiple cardiac comorbidities tended to experience high in-hospital
death rates in the setting of AMI. Full-scale surveillance of Hanoi residents hospitalized with AMI at all Hanoi hospitals is
needed to confirm these findings. Effective strategies to manage Vietnamese patients hospitalized with AMI who have
multiple comorbidities are warranted to improve their short-term prognosis.
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Introduction
The prevalence of persons with multiple comorbidities in the
general population is increasing, even in low-middle income
countries (LMICs) [1,2,3]. Data from the International Network
for Demographic Evaluation of Populations and Their Health
including 8 Asian sites in Vietnam, Bangladesh, Thailand,
Indonesia, and India in 2005 showed that 23% of men and 32%
of women aged 25–64 years reported having at least 1 chronic
health condition, and 5% of men and 9% of women reported
having 2 or more chronic conditions [2]. Patients hospitalized with
acute myocardial infarction (AMI) also have a variety of
cardiovascular (CVD) and non-CVD comorbidities present
[4,5,6,7,8]. Previous studies have suggested that CVD and non-
CVD comorbidities exert a negative impact on in-hospital
complications and mortality in patients hospitalized with AMI,
though these studies have been primarily conducted in high-
income countries [4,5,6,7,8,9].
Vietnam is an LMIC, which has been undergoing an important
epidemiological transition. The overall morbidity and mortality
from Non-Communicable Diseases (NCDs) has been rising rapidly
over the last two decades and the NCDs have become a major
societal problem. CVD is now the leading cause of death in
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Vietnam, accounting for approximately one quarter of all deaths
annually. Moreover, the major risk factors for CVD are either on
the rise or at disturbing levels in the Vietnamese population [10].
Data from the International Network for Demographic Evaluation
of Populations and Their Health in 2005 showed that the
prevalence of persons with 2 or more chronic conditions was
approximately 6% for Vietnamese men and 7% for women [2].
Despite the important impact of multiple comorbidities on the
prognosis of patients hospitalized with AMI, to the best of our
knowledge no studies have reported the prevalence of CVD and
non-CVD comorbidities and their impact on hospital manage-
ment practices and short-term outcomes among adults hospital-
ized with AMI in Vietnam. The objectives of this observational
study were to describe the prevalence of several CVD and non-
CVD comorbidities and their impact on hospital management, in-
hospital clinical complications, and mortality in patients hospital-
ized with a first AMI during 2010 at the Vietnam National Heart
Institute in Hanoi.
Methods
Ethics Statement
The Institutional Review Board at the Institute of Population,
Health and Development approved this study. The study was
conducted with a waiver of patient consent approved by the
institute’s Institutional Review Board. Patient records/information
was anonymized and de-identified prior to analysis.
Study Setting
This study was carried out at the Vietnam National Heart
Institute [11]. This facility is a 250 bed- tertiary care medical
center in Hanoi (2009 census = 6.5 million), which treats the
majority of Hanoi residents hospitalized with acute coronary
disease and other NCDs.
Case Ascertainment Approaches
Computerized printouts of patients discharged from the
Vietnam National Heart Institute in 2010 with possible AMI
were obtained and International Classification of Disease codes for
possible AMI (I20-I25) were reviewed. Cases of possible AMI were
independently validated according to predefined criteria for AMI
by two cardiologists. The diagnosis of AMI was made on the basis
of criteria developed by the World Health Organization which
includes a suggestive clinical history, serum enzyme elevations
above the hospital’s normal range (normal ranges: Troponin I,
0.5 ng/ml, Troponin T,0.01 ng/ml, CK-MB ,7–25 U/L, CK:
Male: 38–174 U/L, Female: 26–140 U/L), and serial electrocar-
diographic (ECG) findings during hospitalization consistent with
the presence of AMI; at least 2 of these 3 criteria needed to be
present for an AMI to have occurred [12]. A total of 315 residents
of the city of Hanoi who satisfied criteria for the diagnosis of AMI
were identified. Since the majority (302 patients) of this population
was hospitalized for a first AMI (96%), we restricted our patient
population to those with an initial AMI based on the review of
information obtained from hospital medical records. Our patient
population was also further classified into those with ST segment
elevation AMI (STEMI) and non-ST segment elevation AMI
(NSTEMI), using standard classification techniques [13]. Each of
the ECG’s of patients with possible AMI was reviewed by a
physician under the guidance of a senior cardiologist. A small
number of patients with AMI (n= 21) were not able to be classified
as STEMI or NSTEMI due to the poor quality of reviewed ECGs.
Data Collection
We reviewed the paper medical records of all patients who were
admitted with discharge diagnoses suggestive of AMI and
reviewed each of their hospital charts. For each independently
validated case of AMI who satisfied our geographic eligibility
criteria, a variety of socio-demographic, clinical, and medical care
related information was collected from the review of the medical
record and abstracted onto a standardized case-report form by
trained study physicians. Information was collected about patient’s
age, sex, previously diagnosed comorbidities, admission heart rate,
blood pressure, serum glucose and serum lipid levels, AMI type
(STEMI vs. NSTEMI), receipt of effective cardiac medications
during the index hospitalization (e.g., Angiotensin converting
enzyme inhibitors-ACEIs; Angiotensin II receptor blockers-ARBs,
beta blockers) and coronary interventional procedures (e.g.,
percutaneous coronary intervention -PCI, coronary artery bypass
surgery -CABG), clinically significant in-hospital complications
(e.g., heart failure, stroke, atrial fibrillation), hospital discharge
status, and length of hospital stay.
Comorbidities in the present study were defined as those
chronic conditions that were previously diagnosed, and had been
documented, in the medical history section of reviewed hospital
charts, and did not include any conditions that may have been
newly diagnosed during the patient’s hospital admission. Thus,
there were no clinical or laboratory criteria that were used to make
the final diagnoses for these conditions. Comorbidities in this
patient population were categorized into 2 groups: CVD and non-
CVD comorbidities. Seven CVD comorbidities were considered
including atrial fibrillation, coronary heart disease -CHD (prior
angina, CHD, MI, CABG, and PCI), diabetes, heart failure,
hypertension, hyperlipidermia, and stroke. Six non-CVD comor-
bidities including anemia, asthma, cancer, chronic obstructive
pulmonary disease (COPD), gastro-intestinal (GI) bleeding/peptic
ulcer, and chronic renal disease were examined. The selection of
these conditions was made based on findings from previous studies
that have examined the associations of these comorbdiities with
the prognosis of patients hospitalized with AMI [4,5,6,7,8] and
based on their prevalence in this patient sample.
The primary outcome of the present study was the in-hospital
case- fatality rate (CFR). Secondary outcomes included hospital
management practices (e.g., use of aspirin, ACEIs/ARBs, beta
blockers, statins, PCI, and CABG), hospital clinical complications
(e.g., atrial fibrillation, heart failure, cardiogenic shock), and
hospital length of stay. In terms of hospital clinical complications,
atrial fibrillation included the documentation of new atrial
fibrillation in the hospital medical record or occurrence of typical
electrocardiographic changes consistent with this diagnosis. Heart
failure was indicated by clinical or radiographic evidence of
pulmonary edema or bilateral basilar rales with an S3 gallop.
Cardiogenic shock was defined as a systolic blood pressure of less
than 90 mmHg in the absence of hypovolemia and associated with
cyanosis, cold extremities, changes in mental status, persistent
oliguria, or congestive heart failure.
Data Analysis
The overall prevalence of single and multiple comorbidities in
this population was calculated in a standard manner. The number
of CVD comorbidities was categorized into 3 categories (0, 1, and
$2) and the number of non-CVD comorbidites was categorized
into 2 categories (0 and $1). Data were presented as percentages
for categorical variables and compared using the chi-square or
Fisher exact tests if expected values were less than 5; medians (inter
quartile range- IQR) for continuous variables were calculated and
compared using the Kruskal-Wallis tests.
Comorbidities in Patients Hospitalized with a First AMI
PLOS ONE | www.plosone.org 2 October 2014 | Volume 9 | Issue 10 | e108998
Logistic regression models were used to examine the impact of
number of comorbidities on in-hospital CFRs. A multivariable
logistic regression model was adjusted for several patient associated
characteristics that significantly differed according to number of
comorbidities in unadjusted analyses (age, MI characteristic:
STEMI vs. NSTEMI). The most common clusters of co-existing
comorbidities were identified and in-hospital CFRs associated with
these clusters were reported. Two-sided analytic tests were used
and a p value less than 0.05 was considered to be statistically
significant. All analyses were performed using STATA 11.0
(StataCorp. TX).
Results
The study population consisted of 302 Hanoi residents
hospitalized with a first AMI at the VNHI in 2010. The average
age of study patients was 66 years and one third were women.
Seventy three percent of patients developed an STEMI. The
overall in-hospital mortality was 7.0%.
Prevalence of CVD and Non-CVD Comorbidities
The mean and median number of CVD comorbidities in this
population were 0.9 and 1 respectively (range: 0-3; only 2 patients
had 3 conditions). Two thirds of patients had at least 1 CVD
comorbidity previously diagnosed. The proportions of patients
with none, any 1, and any 2 or more CVD comorbidities were
34%, 42%, and 24%, respectively. Among the cardiac comorbid
conditions examined, hypertension was the most commonly
reported (59%) followed by diabetes (17%) (Figure 1).
The majority (90%) of patients had none of the non-CVD
comorbidities examined and only 10% had any 1 or more non-
CVD comorbidities previously diagnosed. Among the non-CVD
comorbidities, GI bleeding/ulcer was the most commonly
reported (7%) (Figure 1). Since the prevalence of non-CVD
comorbidities was very low in this population, we did not perform
further analyses according to the number of non-CVD comor-
bidities present.
Study Population Characteristics
Patients with any CVD comorbidity were significantly older and
more likely to have developed a NSTEMI than patients without
any previously diagnosed CVD comorbidity (Table 1). On
admission, patients with any CVD comorbidity had significantly
higher blood pressure results, higher plasma glucose levels, but
lower estimated glomerular filtration rate (eGFR) findings
compared to patients without any CVD comorbidity.
Hospital Management Practices
Overall, during the first 24 hours after hospital admission, the
use of aspirin and lipid lowering agents was high (.90%) as was
the use of ACE inhibitors (,70%); however, the use of beta-
blockers was comparatively low (,30%) (Table 2).
During the first 24 hours after hospital admission, although
there were no statistically significant differences in medication
utilization both singly and in combination in relation to the
number of CVD comorbidities previously diagnosed, there was a
decreasing trend in the proportion of patients who received
effective cardiac medications as the number of cardiac comorbid-
ities increased (Table 2). Similarly, the proportion of patients
undergoing PCI tended to decrease with increasing number of
CVD comorbidities present (63% to 53%). Similar findings were
Figure 1. Prevalence of Selected Cardiovascular and Non-Cardiovascular Comorbidities among Patients Hospitalized with Acute
Myocardial Infarction. CHD, coronary heart disease; COPD, chronic obstructive pulmonary disease; GI, gastro-intestinal; CKD, chronic kidney
disease.
doi:10.1371/journal.pone.0108998.g001
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observed when we examined the use of medications and cardiac
procedures during the entire hospitalization.
In-Hospital Clinical Complications
During hospitalization, although there were no statistically
significant differences with regards to the risk of developing
important clinical complications in relation to the number of CVD
comorbidities, there was an increasing trend in the development of
heart failure (from 11% to 18%), and recurrent angina (4% to 7%)
as the number of CVD comorbidities increased (Table 2).
However, there was a decreased likelihood of developing
cardiogenic shock (5% to 3%) and ventricular fibrillation/cardiac
arrest (7% to 4%) as the number of CVD comorbidities increased.
During hospitalization, although there were no statistically
significant differences in terms of the risk of dying according to the
number of CVD comorbidities, the crude in-hospital CFRs tended
to be lower in patients with any 1 CVD comorbidity compared to
those without any CVD comorbidity (5.5% vs. 6.8%, Table 2).
After adjusting for age and AMI associated characteristic (STEMI
vs. NSTEMI), there was a 29% lower risk of dying for patients
with any 1 cardiac condition compared with patients without any
CVD condition (adjusted OR: 0.71; 95%CI: 0.22–2.31).
On the other hand, the crude in-hospital CFR tended to be
higher in patients with 2 or more CVD conditions compared to
those without any CVD condition (9.7% vs. 6.8%, Table 2). After
adjusting for age and AMI related characteristic, patients with
multiple CVD comorbidities were 40% more likely to have died
during hospitalization compared to patients without any cardiac
condition (adjusted OR: 1.40; 95%CI: 0.40–4.84). Hospital length
of stay did not differ according to the number of CVD
comorbidities previously diagnosed.
Common Clusters of CVD Comorbidities
The most common clusters of CVD comorbidities included
‘‘hypertension + diabetes’’ (n = 40,13.3%), ‘‘hypertension + stroke’’
(n = 18, 6.0%), ‘‘hypertension + CHD’’ (n = 12, 4.0%), and
‘‘hypertension + hyperlipidemia’’ (n = 13, 4.3%); the in-hospital
CFRs for these clusters were 5.0%, 9.5%, 25.0% and 7.7%,
respectively. Hypertension was included in all common clusters,
and the in-hospital CFR for patients with both hypertension and
CHD conditions was the highest, being approximately 3 times as
high as that of the whole study population (overall CFR of 7.0%).
Table 1. Study Population Characteristics According to Number of Cardiovascular Comorbidities.
0 (n =103) 1 (n =127) $2 (n=72) p value*
Age (mean, SD), years 63(13) 68(11) 67(10) 0.003
Male 76(73.8) 83(65.4) 42(58.3) 0.10
Ethnicity (n,%)
Kinh** 100(97.1) 127(100) 69(95.8) 0.09
Minority 3(2.9) 0(0) 3(4.2)
MI characteristic (n,%)
STEMI" 80(83.3) 84(72.4) 43(62.3) 0.010
Non-STEMI 16(16.7) 32(27.6) 26(37.7)
Clinical parameters on admission (median, IQR)
Heart rate (beats/min) 82(72–97) 87(72–102) 90(79–102) 0.16
Systolic blood pressure (mmHg) 120(100–130) 120(110–145) 130(120–140) 0.002
Diastolic blood pressure (mmHg) 70(60–80) 80(70–90) 80(70–90) 0.008
Laboratory findings on admission (median, IQR)
Cholesterol (mmol/L) 4.5(3.9–5.0) 4.6(4.0–5.1) 4.4(4.0–5.3) 0.84
LDL (mmol/L) 2.7(2.1–3.1) 2.8(2.3–3.1) 2.6(2.2–3.4) 0.71
Glucose (mmol/L) 6.8(5.4–9.0) 7.5(5.7–9.0) 8.5(6.1–12.2) 0.008
eGFR (ml/min/1.73 m2)u 75(62–92) 67(52–80) 68(54–89) 0.002
Cardiovascular comorbidity (n,%)
Atrial fibrillation NA 2(1.6) 2(2.8)
Coronary heart disease NA 4(3.1) 13(18.1)
Diabetes NA 10(7.9) 41(56.9)
Heart failure NA 0(0) 1(1.4)
Hypertension NA 108(85) 71(98.6)
Hyperlipidemia NA 1(0.8) 13(18.1)
Stroke NA 2(1.6) 18(25)
SD: Standard deviation; IQR: Inter quartile range; STEMI: ST segment elevation AMI; LDL: Low Density Lipoprotein
**The Kinh people are the majority ethnic group in Vietnam, comprising 87% of the population (census 2009)
"data missing in 21 patients
ueGFR: glomerular filtration rate was calculated based on CKD-EPI Equation
*p values from chi-square or Fisher exact tests for categorical variables and Kruskal-Wallis tests for continuous variables.
doi:10.1371/journal.pone.0108998.t001
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Discussion
The results of our pilot study in Hanoi, Vietnam showed that
approximately two thirds of patients hospitalized with a first AMI
at the largest tertiary care center in Hanoi had at least 1 CVD
comorbidity present. In terms of non-CVD comorbidity, the
majority of our study sample had none, and only a tenth had any 1
or more of these conditions. Patients with multiple CVD
comorbidities were more likely to be older, to have developed a
NSTEMI, and tended to be at higher risk for dying during
hospitalization compared with patients without any CVD comor-
bidity.
Prevalence of CVD and Non-CVD Comorbidities
Our study showed that nearly one half of patients hospitalized
with a first AMI had any 1, and a quarter had any 2 or more,
CVD comorbidities; only one tenth of the study population had at
least 1 non-CVD comorbidity previously diagnosed. Both the
average number of comorbidities, and prevalence of multiple
comorbidities, in our study population were lower than those
reported in studies from high-income countries [4,5,6,7,8,9]
including Spain, Denmark, the United States and Switzerland.
These differences may be explained partially by the fact that our
study population was relatively younger and included only patients
hospitalized with their first AMI. However, given the aging
Vietnamese population, and the increasing adoption of a western
style diet and various lifestyle practices, it is expected that the
prevalence of patients with multiple chronic conditions will
continue to increase in Vietnam. Inasmuch, monitoring trends
in the frequency of individual and multiple comorbidities among
patients hospitalized with AMI will be of continued importance to
inform health systems and practitioners to design and provide
more optimal patient care for these complex patients.
In our study, hypertension was found to be the most prevalent
cardiac condition followed by diabetes. These findings are
consistent with the results of other studies in LMICs
[14,15,16,17] and in high-income countries [4,5,6,7,8] where the
prevalence of hypertension has ranged from approximately 50%–
75%, and the prevalence of diabetes has ranged from 17%–46%
in patients hospitalized with AMI. However, the prevalence of
hyperlipidemia in our study was relatively low (5%) compared to
that of other LMICs where the prevalence has ranged from 15–
30% [14,15,16,17]. GI bleeding/ulcer was found to be the most
common non-CVD comorbidity in our patient population and
other conditions were found at extremely low rates. These findings
are in contrast to those observed in high-income countries [4,7,8]
where chronic kidney disease, COPD, and depression have been
noted in a significant proportion of these diverse study popula-
Table 2. Study Outcomes According to Number of Cardiovascular Comorbidities.
0 (n =103) 1 (n =127) $2 (n=72) p value*
Management in the first 24 hours after admission (n,%)
Aspirin 100(97.1) 123(96.9) 65(90.3) 0.06
ACE Is 73(70.9) 91(71.7) 51(70.8) 0.99
Beta blockers 26(25.2) 25(19.7) 11(15.3) 0.26
Lipid lower agents 96(94.1) 118(92.9) 62(86.1) 0.14
All 4 medications 23(22.3) 22(17.3) 10(13.9) 0.34
Percutaneous coronary intervention 64(62.7) 74(58.3) 38(52.8) 0.42
Management during hospitalization (n,%)
Aspirin 102(99.0) 127(100) 71(98.6) 0.46
ACE Is/ARB 86(83.5) 111(87.4) 58(80.6) 0.42
Beta blockers 34(33.0) 41(32.3) 16(22.2) 0.24
Lipid lower agents 97(94.2) 118(92.9) 63(87.5) 0.25
All 4 medications 30(29.1) 36(28.3) 16(22.2) 0.56
Hospital cardiac procedures (n,%)
Cardiac catheterization 84(81.6) 95(74.8) 54(75.0) 0.42
Percutaneous coronary intervention 73(70.9) 87(68.5) 47(65.3) 0.74
Coronary artery bypass surgery 3(3.0) 1(0.8) 0(0) 0.36
Hospital complications (n,%)
Atrial fibrillation 2(1.9) 2(1.6) 0(0) 0.68
Cardiogenic shock 5(4.9) 5(3.9) 2(2.8) 0.87
Heart failure 11(10.7) 15(11.8) 13(18.1) 0.32
Recurrent angina 4(3.9) 6(4.7) 5(6.9) 0.65
Stroke 0(0) 1(0.8) 0(0) 0.99
Ventricular fibrillation or cardiac arrest 7(6.8) 6(4.7) 3(4.2) 0.76
In-hospital case-fatality rates (n,%) 7(6.8) 7(5.5) 7(9.7) 0.53
Length of hospital stay (median, IQR), days 4(3–7) 4(2–5) 4(2–6) 0.17
ACE-Is: Angiotensin converting enzyme inhibitors; ARBs: Angiotensin II receptor blockers
*p values from chi-square or Fisher exact tests for categorical variables and Kruskal-Wallis tests for continuous variables.
doi:10.1371/journal.pone.0108998.t002
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tions. For example, data from more than 30,000 patients with an
acute coronary syndrome in the nationwide AMIS Plus registry in
Switzerland between 2002–2012 showed that 7%, 6%, and 2% of
patients reported having kidney disease, chronic lung disease, and
a GI ulcer, respectively [9]. Similarly, in a study of more than
5,000 patients hospitalized with AMI in Spain between 2003–
2009, the prevalence rates of kidney disease, chronic lung disease,
depression, and GI ulcer were 11%, 16%, 4%, and 0.5%,
respectively, in 2009 [4]. Previous studies from LMICs
[14,15,16,17] have failed to report the frequency of non-CVD
comorbidities, so we were unable to compare our findings with the
data from other LMICs.
Factors Associated with Multiple Comorbidities
In our study population, patients with multiple cardiac
comorbidities were more likely to be older, to have developed a
NSTEMI, and to have higher serum glucose, but lower eGFR
findings, compared with patients without any cardiac comorbidity.
This finding is consistent with previous studies in the setting of
AMI [4,5,6,7,8,9], as well as studies in general population samples
from LMICs [1,2,3,18]. For example, in the Worcester Heart
Attack Study of nearly 3,000 patients hospitalized with AMI in
central Massachusetts (United States) between 2003–2007,
patients with multiple chronic conditions were more likely to be
older, female, to have developed an NSTEMI, and to have higher
serum glucose, but lower eGFR and serum cholesterol levels, at
the time of hospital admission compared to those without any
cardiac comorbidity [8]. Identifying patient characteristics associ-
ated with multiple cardiac comorbidities is important to inform
interventions designed to decrease the prevalence of multiple
comorbidities in these individuals.
Hospital Management Practices
Although there were no statistically significant differences in
hospital management practices in relation to the number of
chronic conditions previously diagnosed in the present study, our
results suggest that there was a decreasing trend in the receipt of
effective cardiac medications and PCI as the number of cardiac
comorbidities increased, consistent with the findings from several
developed countries [7,8,9]. For example, a study of nearly 3,000
patients with AMI in 53 hospitals in Ontario, Canada between
1999–2003 demonstrated that the number of pre-existing condi-
tions was inversely associated with the receipt of coronary
reperfusion therapy [7]. Similarly, data from the AMIS Plus
registry found that patients with multiple (CVD and non-CVD)
comorbidities were less likely to have received effective cardiac
medications and coronary reperfusion therapy compared to
patients with no comorbidity [9].
Patients with multiple comorbidities are challenging to treat due
to issues related to possible medication contraindications and their
high rates of adverse events. Current management guidelines in
Vietnam focus only on patients with a single condition and not on
those with multiple conditions. Thus, developing comprehensive
management strategies for these patients is urgently needed. One
such approach to consider would be a patient-and family centered
approach to care throughout the health system [19].
In-hospital Complications and Death Rates
Our data showed that as the number of CVD comorbidities
increased, the risk of developing heart failure and cardiogenic
shock increased, as did the number of patients who died during
hospitalization. These findings are consistent with previous studies
[4,5,8,9]. For example, a nationwide study in Denmark including
more than 200,000 patients hospitalized with a first AMI between
1984–2008 found that patients with multiple comorbidities
experienced higher short- and long-term mortality compared to
patients without multiple comorbidities [5].
In the present study, we also found that the risk of ventricular
fibrillation or cardiac arrest tended to decrease as the number of
CVD comorbidities increased. Similar findings have been reported
in patients with other conditions, such as heart failure, in which
the risk of non-sudden death and total mortality increased as the
number of comorbidities increased, whereas the risk of sudden
death/ventricular fibrillation decreased [20].
There are several potential explanations for these findings. First,
patients with multiple comorbidities tend to be older and female,
and older age and female sex have been found to be independent
risk factors for mortality in patients with AMI [21,22,23,24].
Second, patients with multiple comorbidities may misinterpret the
symptoms of AMI and delay seeking timely medical care.
Furthermore, patients with multiple comorbidities were less likely
to be treated with effective medications and coronary interventions
that may increase their risk of dying in hospital [7,8,9]. Finally,
patients with multiple comorbidities tend to develop clinical
complications that can contribute to higher mortality. More
educational approaches and interventional efforts targeted at
patients with multiple comorbidities are needed to improve their
hospital outcomes.
Common Clusters of Multiple CVD Comorbidities
Our study found that the most common clusters of chronic
CVD comorbidities were ‘‘hypertension and diabetes’’, ‘‘hyper-
tension and stroke’’, ‘‘hypertension and CHD’’, and ‘‘hypertension
and hyperlipidemia’’. These findings are in line with the results of
other studies in patients with AMI from high-income countries [8],
as well as data from general population samples [25]. Identifying
the common patterns of chronic comorbidities in patients
hospitalized with AMI will help in the design of effective
management strategies in these difficult to treat patients.
Study Strengths and Limitations
This study is the first to have examined the prevalence of CVD
and non-CVD comorbidities and their impact on short-term
outcomes in patients hospitalized with AMI in Vietnam. The study
has several limitations that must be kept in mind in interpreting
our study results, however. First, since the population included
only patients hospitalized at one hospital, the Vietnam National
Heart Institute in Hanoi, the generalizability of our findings to
patients admitted to other hospitals in Hanoi is limited and
unknown. Since the sample size in the present study was small, we
were underpowered to detect meaningful differences in other
patient characteristics, hospital management practices, and short-
term outcomes. Third, due to the nature of the study’s
retrospective design, we likely underestimated the prevalence of
comorbidities in our study population. We also did not have
information on several patient-associated characteristics (e.g.,
socioeconomic status, psychological factors, body mass index)
which may have confounded some of the observed associations
[1,3]. We had very limited information on medication contra-
indications; therefore, we were unable to carry out an analysis
restricted to patients without contraindications to the medications
examined, and likely underestimated the use of appropriate
medications. Finally, because patients who died before hospital-
ization for AMI were not included, our findings are only
generalizable to patients hospitalized with AMI.
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Conclusions
In summary, our findings highlight the importance of identi-
fying patients hospitalized with AMI who have multiple CVD
comorbidities to provide better care to these high risk and complex
patients, and therefore, improve their short-term prognosis.
Continued monitoring of trends in multiple comorbidities in
patients hospitalized with AMI and other conditions of major
public health importance, such as stroke, cancer, and chronic lung
disease, in Vietnam remains of considerable clinical and public
health importance.
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